<DOC>
	<DOCNO>NCT00849342</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study investigate effect switch basal insulin treatment Levemir® body weight obese diabetic patient . A local extension conduct Slovenia order reach plan 400 patient sub-analysis Slovenian patient . Included study retrospective part evaluate weight progress since initiation insulin treatment another basal insulin and/or oral antidiabetic drug ( OAD ) and/or bolus insulin therapy . Retrospective data collect baseline approximately 6 12 month start insulin detemir therapy .</brief_summary>
	<brief_title>Observational Study Levemir® Obese Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Diabetes mellitus ( Type 1 type 2 ) BMI great 27 kg/m^2 , 3 kg weight increase since start insulin therapy Subjects currently treat insulin detemir Subjects previously enrol study ; Subjects hypersensitivity insulin detemir excipients . Women pregnant , breast feeding intention become pregnant within next 12 month Female patient remind use adequate contraceptive study , relevant .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>